Zobrazeno 1 - 10
of 2 817
pro vyhledávání: '"Sierra MS"'
Autor:
Jarod T. Griffin MD, David C. Landy MD, PhD, Charles A. Mechas MD, Mark R. Nazal MD, MPH, Jeffrey A. Foster MD, Wyatt G.S. Southall BS, Maaz Muhammad MD, Carlos R. Sierra MS, BS, Eric S. Moghadamian MD, Arjun Srinath MD, FAAOS, MPH, Arun Aneja MD, PhD
Publikováno v:
Foot & Ankle Orthopaedics, Vol 9 (2024)
Introduction/Purpose: Avascular necrosis (AVN) is a complication of talar neck fractures associated with chronic pain and poor functional outcomes. Hawkins sign, the radiographic presence of subchondral lucency seen in the talar dome 6 to 8 weeks aft
Externí odkaz:
https://doaj.org/article/4d074d8dac014963962cbb004998f2cf
Autor:
Porras C; Agencia Costarricense de Investigaciones Biomédicas, San José, Costa Rica., Romero B; Agencia Costarricense de Investigaciones Biomédicas, San José, Costa Rica., Kemp T; Frederick National Laboratory, Frederick, MD, USA., Fantin R; Agencia Costarricense de Investigaciones Biomédicas, San José, Costa Rica., Herrero R; Agencia Costarricense de Investigaciones Biomédicas, San José, Costa Rica., Hildesheim A; Agencia Costarricense de Investigaciones Biomédicas, San José, Costa Rica., Ocampo R; Agencia Costarricense de Investigaciones Biomédicas, San José, Costa Rica., Sierra MS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Gail MH; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Schussler J; Information Management Services, Silver Spring, MD, USA., Schiller JT; Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Lowy DR; Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Pinto LA; Frederick National Laboratory, Frederick, MD, USA., Liu D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Kreimer AR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Publikováno v:
Journal of the National Cancer Institute. Monographs [J Natl Cancer Inst Monogr] 2024 Nov 01; Vol. 2024 (67), pp. 329-336.
Autor:
Slimovitch R; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.; Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA., Shing JZ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Fantin R; Agencia Costarricense de Investigaciones Biomédicas (ACIB-FUNIN), Formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica., Vanegas JC; Agencia Costarricense de Investigaciones Biomédicas (ACIB-FUNIN), Formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica., Porras C; Agencia Costarricense de Investigaciones Biomédicas (ACIB-FUNIN), Formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica., Herrero R; Agencia Costarricense de Investigaciones Biomédicas (ACIB-FUNIN), Formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica., Shiels MS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Sierra MS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Stephens ES; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Hildesheim A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Kreimer AR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Calderón A; Caja Costarricense de Seguro Social, Proyecto de Fortalecimiento de la Atención del Cáncer, San José, Costa Rica., Carvajal LJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.; Agencia Costarricense de Investigaciones Biomédicas (ACIB-FUNIN), Formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica.
Publikováno v:
Lancet regional health. Americas [Lancet Reg Health Am] 2024 Aug 27; Vol. 38, pp. 100872. Date of Electronic Publication: 2024 Aug 27 (Print Publication: 2024).
Autor:
Fantin R; Agencia Costarricense de Investigaciones Biomédicas, Fundación INCIENSA, San José, Costa Rica; Centro Centroamericano de Población, Universidad de Costa Rica, Costa Rica. Electronic address: rfantin@acibfunin.com., Sierra MS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Vaccarella S; International Agency for Research on Cancer (IARC), Lyon, France., Herrero R; Agencia Costarricense de Investigaciones Biomédicas, Fundación INCIENSA, San José, Costa Rica., Barboza-Solís C; Facultad de Odontología, Universidad de Costa Rica, Costa Rica. Electronic address: cristina.barbozasolis@ucr.ac.cr.
Publikováno v:
Cancer epidemiology [Cancer Epidemiol] 2024 Aug; Vol. 91, pp. 102604. Date of Electronic Publication: 2024 Jun 27.
Autor:
Kamuyu G; Virus Reference Department, Public Health Microbiology Division, UK Health Security Agency, London, UK., Coelho da Silva F; Virus Reference Department, Public Health Microbiology Division, UK Health Security Agency, London, UK., Tenet V; International Agency for Research on Cancer (IARC/WHO) Early Detection, Prevention and Infections Branch, Lyon, France., Schussler J; Information Management Services Inc, Silver Spring, MD, USA., Godi A; Virus Reference Department, Public Health Microbiology Division, UK Health Security Agency, London, UK., Herrero R; Agencia Costarricense de Investigaciones Biomédicas (ACIB) formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA (FUNIN), San José, Costa Rica., Porras C; Agencia Costarricense de Investigaciones Biomédicas (ACIB) formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA (FUNIN), San José, Costa Rica., Mirabello L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Schiller JT; Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Sierra MS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Kreimer AR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Clifford GM; International Agency for Research on Cancer (IARC/WHO) Early Detection, Prevention and Infections Branch, Lyon, France., Beddows S; Virus Reference Department, Public Health Microbiology Division, UK Health Security Agency, London, UK. simon.beddows@ukhsa.gov.uk.; Blood Safety, Hepatitis, Sexually Transmitted Infections and HIV Division, UK Health Security Agency, London, UK. simon.beddows@ukhsa.gov.uk.
Publikováno v:
Nature communications [Nat Commun] 2024 Feb 21; Vol. 15 (1), pp. 1608. Date of Electronic Publication: 2024 Feb 21.
Autor:
Carvajal LJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.; Agencia Costarricense de Investigaciones Biomédicas (ACIB-FUNIN), formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica., Shing JZ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA., Vanegas JC; Agencia Costarricense de Investigaciones Biomédicas (ACIB-FUNIN), formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica., González E; Agencia Costarricense de Investigaciones Biomédicas (ACIB-FUNIN), formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica.; Caja Costarricense de Seguro Social, Departamento de Patología, Hospital Dr. Enrique Baltodano Briceño, Guanacaste, Costa Rica., Guillén D; Agencia Costarricense de Investigaciones Biomédicas (ACIB-FUNIN), formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica.; Caja Costarricense de Seguro Social, Departamento de Patología, Hospital Max Peralta, Cartago, Costa Rica., Sierra MS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA., Hildesheim A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA., Porras C; Agencia Costarricense de Investigaciones Biomédicas (ACIB-FUNIN), formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica., Herrero R; Agencia Costarricense de Investigaciones Biomédicas (ACIB-FUNIN), formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica., Torres G; Ministerio de Salud, Registro Nacional de Tumores, San José, Costa Rica., Shiels MS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA., Calderón A; Caja Costarricense de Seguro Social, Proyecto de Fortalecimiento de la Atención del Cáncer, San José, Costa Rica., Kreimer AR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
Publikováno v:
International journal of cancer [Int J Cancer] 2023 May 15; Vol. 152 (10), pp. 2052-2060. Date of Electronic Publication: 2023 Feb 01.
Autor:
Schuind AE; PATH, Washington DC, United States., Rees H; Wits Reproductive Health and HIV Institute (Wits RHI), University of the Witwatersrand, Johannesburg, South Africa., Schiller J; National Cancer Institute, National Institutes of Health, Bethesda, United States., Mugo N; Kenya Medical Research Institute, Nairobi, Kenya and Department of Global Health, University of Washington, Seattle, United States., Dull P; Vaccine Development, Bill & Melinda Gates Foundation, Seattle, United States., Barnabas R; Division of Infectious Diseases, Mass General Hospital, Harvard Medical School, Boston, United States., Clifford GM; Early Detection, Prevention, and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., Liu G; Department of Global Health, University of Washington, Seattle, United States., Madhi SA; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Johannesburg, South Africa., Morse RB; Centre of Vaccinology, University of Geneva, Switzerland., Moscicki AB; Department of Pediatrics, University of California Los Angeles, Los Angeles, United States., Palefsky JM; University of California, San Francisco School of Medicine, San Francisco, United States., Plotkin S; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States., Sierra MS; National Cancer Institute, National Institutes of Health, Bethesda, United States., Slifka MK; Oregon Health & Science University, Beaverton, United States., Vorsters A; Vaccine & Infectious Disease Institute, Centre for the Evaluation of Vaccination, University of Antwerp, Antwerp, Belgium., Kreimer AR; National Cancer Institute, National Institutes of Health, Bethesda, United States., Didierlaurent AM; Centre of Vaccinology, University of Geneva, Switzerland.
Publikováno v:
Preventive medicine reports [Prev Med Rep] 2023 Jul 19; Vol. 35, pp. 102331. Date of Electronic Publication: 2023 Jul 19 (Print Publication: 2023).
Autor:
Carvajal LJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health. Bethesda, Maryland, USA. Agencia Costarricense de Investigaciones Biomédicas, Fundación INCIENSA. San José, Costa Rica.. loretto.carvajal@nih.gov., Herrero R; Agencia Costarricense de Investigaciones Biomédicas, Fundación INCIENSA. San José, Costa Rica.. rherrero@acibcr.com., Angulo MM; Área Rectora de Salud de Garabito, Ministerio de Salud. Jacó, Puntarenas, Costa Rica.. maria.angulo@misalud.go.cr., Schussler J; Information Management Services, Silver Spring. Maryland, USA,. ShusslerJ@imsweb.com., Porras C; Agencia Costarricense de Investigaciones Biomédicas, Fundación INCIENSA. San José, Costa Rica.. cporras@acibcr.com., Ocampo R; Agencia Costarricense de Investigaciones Biomédicas, Fundación INCIENSA. San José, Costa Rica.. rocampo@acibcr.com., Cortés B; Agencia Costarricense de Investigaciones Biomédicas, Fundación INCIENSA. San José, Costa Rica.. bcortes@acibcr.com., Loría V; Agencia Costarricense de Investigaciones Biomédicas, Fundación INCIENSA. San José, Costa Rica.. vloria@acibcr.com., Castrillo H; Agencia Costarricense de Investigaciones Biomédicas, Fundación INCIENSA. San José, Costa Rica.. acastrillo@acibcr.com., Romero B; Agencia Costarricense de Investigaciones Biomédicas, Fundación INCIENSA. San José, Costa Rica.. bromero@acibcr.com., Barrientos G; Agencia Costarricense de Investigaciones Biomédicas, Fundación INCIENSA. San José, Costa Rica.. gbarrientos@acibcr.com., Coronado K; Agencia Costarricense de Investigaciones Biomédicas, Fundación INCIENSA. San José, Costa Rica.. kcoronado@acibcr.com., Ávila C; Agencia Costarricense de Investigaciones Biomédicas, Fundación INCIENSA. San José, Costa Rica.. cavila@acibcr.com., Hildesheim A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health. Bethesda, Maryland, USA.. hildesheima@gmail.com., Rodríguez AC; Consultora independiente. San José, Costa Rica.. rodriguezac2@gmail.com., Jiménez SE; Westat, Rockville. Maryland, USA,. SilviaJimenez@westat.com., Kreimer AR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health. Bethesda, Maryland, USA.. kreimera@mail.nih.gov., Sierra MS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health. Bethesda, Maryland, USA.. monica.sierra@nih.gov.
Publikováno v:
Salud publica de Mexico [Salud Publica Mex] 2023 Apr 21; Vol. 65 (3, may-jun), pp. 253-264. Date of Electronic Publication: 2023 Apr 21.
Autor:
Sierra MS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA monica.sierra@nih.gov., Tsang SH; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Porras C; Agencia Costarricense de Investigaciones Biomédicas (ACIB), formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San Jose, Costa Rica., Herrero R; Agencia Costarricense de Investigaciones Biomédicas (ACIB), formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San Jose, Costa Rica.; Early Detection and Prevention Section, International Agency for Research on Cancer, Lyon, Rhône-Alpes, France., Sampson JN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Cortes B; Agencia Costarricense de Investigaciones Biomédicas (ACIB), formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San Jose, Costa Rica., Schussler J; Information Management Services Inc, Silver Spring, Maryland, USA., Wagner S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc, Frederick, Maryland, USA., Carvajal L; Agencia Costarricense de Investigaciones Biomédicas (ACIB), formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San Jose, Costa Rica., Quint W; DDL Diagnostic Laboratory, Rijswijk, The Netherlands., Kreimer AR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Hu S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.; Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Rodriguez AC; Independent Consultant, San Jose, Costa Rica., Romero B; Agencia Costarricense de Investigaciones Biomédicas (ACIB), formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San Jose, Costa Rica., Hildesheim A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Publikováno v:
Sexually transmitted infections [Sex Transm Infect] 2022 Jul 16. Date of Electronic Publication: 2022 Jul 16.
Autor:
Shing JZ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: jaimie.shing@nih.gov., Hu S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Herrero R; Agencia Costarricense de Investigaciones Biomédicas (ACIB), Fundación INCIENSA, San José, Costa Rica; Early Detection and Prevention Section, International Agency for Research on Cancer, WHO, Lyon, France., Hildesheim A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Porras C; Agencia Costarricense de Investigaciones Biomédicas (ACIB), Fundación INCIENSA, San José, Costa Rica., Sampson JN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Schussler J; Information Management Services, Silver Spring, MD, USA., Schiller JT; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Lowy DR; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Sierra MS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Carvajal L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; Agencia Costarricense de Investigaciones Biomédicas (ACIB), Fundación INCIENSA, San José, Costa Rica., Kreimer AR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2022 Jul; Vol. 23 (7), pp. 940-949. Date of Electronic Publication: 2022 Jun 13.